Nikita Varshneya
Cardiovascular Disease · Clark, NJNPI 1275551103
Payments from drug & device makers
Across 352 payments — averaging $15.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$744
- Abbott$449
- Amgen$412
- AstraZeneca$388
- Johnson & Johnson$351
- Daiichi Sankyo Inc.$329
- plus $3K from 32 others
What the payments were for
- Food & beverage$5,30599%
- Education$361%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amarin Pharma, Inc. | 54 | $744 |
| Abbott | 8 | $449 |
| Amgen | 30 | $412 |
| AstraZeneca | 30 | $388 |
| Johnson & Johnson | 27 | $351 |
| Daiichi Sankyo Inc. | 35 | $329 |
| Merck | 21 | $292 |
| Novartis | 22 | $290 |
| Boehringer Ingelheim | 18 | $255 |
| Boston Scientific | 4 | $170 |
| E.r. Squibb & Sons, L.L.C. | 12 | $140 |
| Esperion Therapeutics, Inc. | 10 | $133 |
| Sanofi-aventis U.S. LLC | 9 | $131 |
| Irhythm Technologies, Inc. | 4 | $130 |
| Pfizer | 9 | $120 |
| Biotronik Inc. | 1 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $102 |
| Cvrx, Inc. | 3 | $96 |
| Bardy Diagnostics, Inc. | 7 | $89 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $70 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $70 |
| Nestle Healthcare Nutrition Inc. | 4 | $60 |
| Novo Nordisk | 4 | $58 |
| Bayer | 3 | $54 |
| Amryt Pharma Holdings Ltd | 3 | $48 |
| Medtronic(2 entities) | 2 | $33 |
| Althera Pharmaceuticals LLC | 2 | $31 |
| QOL Medical, LLC | 2 | $27 |
| Regeneron Healthcare Solutions, Inc. | 2 | $26 |
| Redhill Biopharma Inc. | 2 | $25 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| AbbVie | 1 | $15 |
| GSK | 1 | $14 |
| Ardelyx, Inc. | 1 | $14 |
| Seqirus USA Inc | 1 | $14 |
| Ironwood Pharmaceuticals, Inc | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Impulse Dynamics (USA) Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,341 in reported general payments places this provider in the 65th percentile of 1,006 cardiovascular disease providers in New Jersey.
Other cardiovascular disease in Clark
- Sheila SahniClark$109K
- Robert KippermanMorristown$5.3M
- Sharan MahalBridgewater$3.5M
- Linda GillamMorristown$2.2M
- Mark GelerntHaddon Heights$2M
- Robert FishbergSpringfield$1.9M
- Dilip ViswanathHaddon Heights$1.8M
- Marc CohenNewark$1M
- Jasjit WaliaElizabeth$859K
- Sajjad SabirCamden$742K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.